Amy joined Kaiser Permanente as a managing director in 2016. Amy brings over 25 years of experience in healthcare investing, start-up and corporate operations and health system consulting.
Amy has spent a 15 years in venture capital including Covidien Ventures and Advanced Technology Ventures (ATV). Immediately prior to joining KPV, Amy was the Chief Business Officer of digital health start-up Evidation Health. Amy has led investments and/or board roles in over 15 healthcare companies across digital health, healthcare IT, diagnostics and med device. Earlier in her career, Amy held operating roles at Guidant Corporation and began her career as a management consultant for hospitals at APM/CSC Healthcare.
Amy is a Kauffman Venture Fellow as well as founder and president of MedtechWomen. She holds a BA in Economics from Yale University and an MBA from the University of California at Berkeley.
Dec 9th, 2018 — SAN FRANCISCO/January 5, 2018/PRNewswire – Genome Medical today announced a Series A-1 financing… read more